IL115536A - Benzylthiazolidine-2,4-dione and benzyloxazolidine-2,4-dione derivatives pharmaceutical compositions containing them and process for their preparation - Google Patents
Benzylthiazolidine-2,4-dione and benzyloxazolidine-2,4-dione derivatives pharmaceutical compositions containing them and process for their preparationInfo
- Publication number
- IL115536A IL115536A IL11553695A IL11553695A IL115536A IL 115536 A IL115536 A IL 115536A IL 11553695 A IL11553695 A IL 11553695A IL 11553695 A IL11553695 A IL 11553695A IL 115536 A IL115536 A IL 115536A
- Authority
- IL
- Israel
- Prior art keywords
- dione
- chem
- alkyl
- hydrogen
- formula
- Prior art date
Links
- ZWZFFTHXSRRHOU-UHFFFAOYSA-N 3-benzyl-1,3-oxazolidine-2,4-dione Chemical class O=C1COC(=O)N1CC1=CC=CC=C1 ZWZFFTHXSRRHOU-UHFFFAOYSA-N 0.000 title 1
- JIMXJAFZPUUCAD-UHFFFAOYSA-N 3-benzyl-1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1CC1=CC=CC=C1 JIMXJAFZPUUCAD-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000004104 gestational diabetes Diseases 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 abstract 2
- 102000016912 Aldehyde Reductase Human genes 0.000 abstract 1
- 108010053754 Aldehyde reductase Proteins 0.000 abstract 1
- 208000002249 Diabetes Complications Diseases 0.000 abstract 1
- 206010012655 Diabetic complications Diseases 0.000 abstract 1
- 208000004930 Fatty Liver Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010019708 Hepatic steatosis Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 208000010706 fatty liver disease Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24387694 | 1994-10-07 | ||
| JP13678895 | 1995-06-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL115536A0 IL115536A0 (en) | 1996-01-19 |
| IL115536A true IL115536A (en) | 1999-07-14 |
Family
ID=26470291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11553695A IL115536A (en) | 1994-10-07 | 1995-10-06 | Benzylthiazolidine-2,4-dione and benzyloxazolidine-2,4-dione derivatives pharmaceutical compositions containing them and process for their preparation |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US5703096A (cs) |
| EP (1) | EP0708098B1 (cs) |
| KR (1) | KR100250175B1 (cs) |
| CN (1) | CN1056840C (cs) |
| AT (1) | ATE177088T1 (cs) |
| AU (1) | AU688573B2 (cs) |
| CA (1) | CA2159938A1 (cs) |
| CZ (1) | CZ261095A3 (cs) |
| DE (1) | DE69508029T2 (cs) |
| DK (1) | DK0708098T3 (cs) |
| ES (1) | ES2132536T3 (cs) |
| FI (1) | FI954763A7 (cs) |
| GR (1) | GR3030207T3 (cs) |
| HU (1) | HUT72642A (cs) |
| IL (1) | IL115536A (cs) |
| MX (1) | MX9504261A (cs) |
| NO (1) | NO305954B1 (cs) |
| NZ (1) | NZ280181A (cs) |
| RU (1) | RU2122998C1 (cs) |
| TW (1) | TW400329B (cs) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038427A1 (en) * | 1995-06-02 | 1996-12-05 | Sankyo Company, Limited | Aromatic oxyimino derivatives |
| NO318765B1 (no) * | 1995-07-03 | 2005-05-02 | Sankyo Co | Anvendelse av en HMG-CoA reduktaseinhibitor og en insulinsensibilisator til fremstilling av et medikament for forebyggelse eller behandling av arteriosklerose eller xantom, samt pakket farmasoytisk preparat som omfatter de to midlene i separate porsjoner. |
| EP0783888A1 (en) | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
| IL120443A (en) * | 1996-03-18 | 2000-07-16 | Sankyo Co | Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis |
| NZ332136A (en) * | 1996-04-04 | 1999-08-30 | Sankyo Co | Phenylalkylcarboxylic acid derivatives useful for treating hyperglycemia |
| US5919782A (en) * | 1996-05-06 | 1999-07-06 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| US5889025A (en) * | 1996-05-06 | 1999-03-30 | Reddy's Research Foundation | Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| ZA973848B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
| CA2257284C (en) * | 1996-05-31 | 2005-10-04 | Sankyo Company Limited | Remedy for autoimmune diseases |
| USRE39266E1 (en) * | 1996-07-01 | 2006-09-05 | Dr. Reddy's Laboratories, Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| BR9711098B1 (pt) | 1996-07-01 | 2011-10-04 | compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas. | |
| US6114526A (en) * | 1996-07-01 | 2000-09-05 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US6372750B2 (en) | 1996-07-01 | 2002-04-16 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
| ATE399545T1 (de) * | 1996-11-08 | 2008-07-15 | Nippon Chemiphar Co | Mittel zur verringerung der eigeweidefette |
| HUP9902721A2 (hu) * | 1997-11-25 | 1999-12-28 | The Procter & Gamble Co. | Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület |
| US6019229A (en) * | 1997-12-18 | 2000-02-01 | Fleetguard, Inc. | Self-centering, floating retainer for spin-on filter |
| MY123337A (en) | 1998-05-11 | 2006-05-31 | Takeda Chemical Industries Ltd | Oxyiminoalkanoic acid derivatives. |
| US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
| DE60044342D1 (de) * | 1999-04-07 | 2010-06-17 | Daiichi Sankyo Co Ltd | Aminderivate |
| EP1229026A4 (en) * | 1999-11-10 | 2003-09-24 | Takeda Chemical Industries Ltd | ALCOXYIMINOALKANOIC ACID DERIVATIVES |
| US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
| US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
| ATE400271T1 (de) * | 2004-07-28 | 2008-07-15 | Hoffmann La Roche | Aryl-pyridinderivate als 11-beta-hsd1-hemmer |
| CN115887434B (zh) * | 2022-11-23 | 2024-12-24 | 四川大学 | 具有抗氧化作用的药物用于制备治疗多囊卵巢综合征药物的用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| DK173350B1 (da) * | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
| JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
| EP0295828A1 (en) * | 1987-06-13 | 1988-12-21 | Beecham Group Plc | Novel compounds |
| US4728739A (en) * | 1987-06-15 | 1988-03-01 | American Home Products Corporation | Hypoglycemic thiazolidinediones |
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
| WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| GB9017218D0 (en) * | 1990-08-06 | 1990-09-19 | Beecham Group Plc | Novel compounds |
| ES2067945T3 (es) * | 1990-08-23 | 1995-04-01 | Pfizer | Derivados de hidroxiurea hipoglicemica. |
| GB9023583D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
| GB9023584D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
| GB9023585D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
| FR2680512B1 (fr) * | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5420146A (en) * | 1994-05-10 | 1995-05-30 | American Home Products Corporation | Di-oxadiazolidine derivatives as antihyperglycemic agents |
| JPH08143556A (ja) * | 1994-11-15 | 1996-06-04 | Terumo Corp | ジオキソチアゾリジン誘導体及びそれを含有する医薬組成物 |
| JPH08143568A (ja) * | 1994-11-22 | 1996-06-04 | Terumo Corp | ピリドピリミジン誘導体及びそれを含有する医薬組成物 |
| JPH08143566A (ja) * | 1994-11-25 | 1996-06-04 | Terumo Corp | キナゾリン誘導体及びそれを含有する医薬組成物 |
| JP3929512B2 (ja) * | 1995-06-02 | 2007-06-13 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| JP3144624B2 (ja) * | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
-
1995
- 1995-10-05 CA CA002159938A patent/CA2159938A1/en not_active Abandoned
- 1995-10-05 US US08/539,541 patent/US5703096A/en not_active Expired - Fee Related
- 1995-10-05 CZ CZ952610A patent/CZ261095A3/cs unknown
- 1995-10-06 HU HU9502925A patent/HUT72642A/hu unknown
- 1995-10-06 RU RU95117054A patent/RU2122998C1/ru active
- 1995-10-06 MX MX9504261A patent/MX9504261A/es unknown
- 1995-10-06 FI FI954763A patent/FI954763A7/fi unknown
- 1995-10-06 TW TW084110541A patent/TW400329B/zh not_active IP Right Cessation
- 1995-10-06 NO NO953990A patent/NO305954B1/no not_active IP Right Cessation
- 1995-10-06 CN CN95119194A patent/CN1056840C/zh not_active Expired - Fee Related
- 1995-10-06 AU AU33076/95A patent/AU688573B2/en not_active Ceased
- 1995-10-06 KR KR1019950034189A patent/KR100250175B1/ko not_active Expired - Fee Related
- 1995-10-06 IL IL11553695A patent/IL115536A/xx not_active IP Right Cessation
- 1995-10-06 NZ NZ280181A patent/NZ280181A/en unknown
- 1995-10-09 EP EP95307131A patent/EP0708098B1/en not_active Expired - Lifetime
- 1995-10-09 ES ES95307131T patent/ES2132536T3/es not_active Expired - Lifetime
- 1995-10-09 DE DE69508029T patent/DE69508029T2/de not_active Expired - Fee Related
- 1995-10-09 AT AT95307131T patent/ATE177088T1/de active
- 1995-10-09 DK DK95307131T patent/DK0708098T3/da active
-
1997
- 1997-06-18 US US08/878,219 patent/US5780490A/en not_active Expired - Fee Related
-
1998
- 1998-04-21 US US09/063,609 patent/US5972959A/en not_active Expired - Fee Related
-
1999
- 1999-05-13 GR GR990401292T patent/GR3030207T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100250175B1 (ko) | 2000-05-01 |
| RU2122998C1 (ru) | 1998-12-10 |
| DE69508029T2 (de) | 1999-10-21 |
| IL115536A0 (en) | 1996-01-19 |
| HU9502925D0 (en) | 1995-11-28 |
| TW400329B (en) | 2000-08-01 |
| MX9504261A (es) | 1997-01-31 |
| US5780490A (en) | 1998-07-14 |
| US5703096A (en) | 1997-12-30 |
| AU3307695A (en) | 1996-05-02 |
| NO953990D0 (no) | 1995-10-06 |
| CA2159938A1 (en) | 1996-04-08 |
| KR960014124A (ko) | 1996-05-22 |
| GR3030207T3 (en) | 1999-08-31 |
| FI954763A7 (fi) | 1996-04-08 |
| EP0708098B1 (en) | 1999-03-03 |
| CZ261095A3 (en) | 1996-04-17 |
| AU688573B2 (en) | 1998-03-12 |
| DE69508029D1 (de) | 1999-04-08 |
| US5972959A (en) | 1999-10-26 |
| NZ280181A (en) | 1996-11-26 |
| CN1056840C (zh) | 2000-09-27 |
| FI954763A0 (fi) | 1995-10-06 |
| NO953990L (no) | 1996-04-09 |
| DK0708098T3 (da) | 1999-10-04 |
| ATE177088T1 (de) | 1999-03-15 |
| HUT72642A (en) | 1996-05-28 |
| NO305954B1 (no) | 1999-08-23 |
| EP0708098A1 (en) | 1996-04-24 |
| CN1143639A (zh) | 1997-02-26 |
| ES2132536T3 (es) | 1999-08-16 |
| HK1011974A1 (en) | 1999-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL115536A (en) | Benzylthiazolidine-2,4-dione and benzyloxazolidine-2,4-dione derivatives pharmaceutical compositions containing them and process for their preparation | |
| IL118474A0 (en) | Benzimidazole derivatives pharmaceutical compositions containing the same and the use thereof | |
| KR950032188A (ko) | 항당뇨 활성을 갖는 헤테로고리 화합물, 그 제법과 용도 | |
| HU9203638D0 (en) | Aromatic amino-alcohol-derivatives applicables for treatment of diabetes and obesity and pharmaceutical preparatives containing them | |
| NZ503712A (en) | Amidopropionic acid derivatives | |
| EP1213296A4 (en) | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND INTERMEDIATE PRODUCTS OBTAINED DURING THEIR PRODUCTION | |
| EP1609798A4 (en) | CONDENSED HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, AND MEDICAL USE THEREOF | |
| AU4396899A (en) | Remedies for diabetes | |
| BR0111199A (pt) | Compostos heterocìclicos | |
| DE69016866D1 (de) | Verwendung von Bis(4-hydroxyphenylthio)methan-Derivaten zur Behandlung von Diabetes mellitus. | |
| DK0570245T3 (da) | Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse | |
| SI1399156T1 (sl) | Derivati alkiliden pirazolidindiona in njihova uporaba pri zdravljenju diabetesa in debelosti | |
| ZA905736B (en) | Method of treating diabetes mellitus with bisphenol derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |